✦ LIBER ✦

A phase I clinical and pharmacokinetic study of capecitabine (Xeloda®) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours

✍ Scribed by Delord, J P; Pierga, J Y; Dieras, V; Bertheault-Cvitkovic, F; Turpin, F L; Lokiec, F; Lochon, I; Chatelut, E; Canal, P; Guimbaud, R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility of biweekly combination chem

✍ T. Mazard; M. Ychou; S. Thezenas; S. Poujol; F. Pinguet; A. Thirion; J. P. Bleus 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 197 KB

Phase I study of irinotecan and S-1 comb

✍ Yasuhide Yamada; Hisateru Yasui; Ayumu Goto; Tatsuhiro Arai; Takashi Ura; Tetsuy 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 214 KB

A dose finding and pharmacokinetic study

✍ Lorenzo Fornaro; G. Masi; S. Bursi; F. Loupakis; E. Vasile; A. Antonuzzo; S. Chi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 273 KB

A phase I clinical and pharmacokinetic s

✍ Miguel Angel Izquierdo; Margarita García; José Luis Pontón; Marisa Martínez; Vic 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Phase I and pharmacokinetic study of Xel

✍ Vasey, P.A.; Pronk, L.; Twelves, C.; Sparreboom, A.; Wilson, P.; Gordon, R.J.; O 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Phase I and pharmacokinetic study of UCN

✍ Antonio Jimeno; Michelle A. Rudek; Thomas Purcell; Daniel A. Laheru; Wells A. Me 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 438 KB